NuVasive unveiled its C360 cervical spine portfolio and launched a new device on Nov. 30.
The C360 line "is key to our long-term strategy and represents a significant opportunity for growth," said Massimo Calafiore, executive vice president of global business units at NuVasive.
NuVasive also launched the Anterior Cervical Plating system, which aims to reduce post-op complications such as dysphagia, malalignment and adjacent level ossification.
The C360 portfolio also includes Reline Cervical, a posterior fixation system expected to be commercially available in 2021.